EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Integrative High-Throughput RNAi Screening Identifies BRSK1, STK32C and STK40 as Novel Activators of YAP/TAZ

Mandeep K Gill, Siyuan Song, Tania Christova, Liliana Attisano iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26167810 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Mandeep K Gill und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Donnelly Centre, University of Toronto, Toronto, ON M5S 3E1, Canada. Hauptthemen laut MEDLINE: Protein Serine-Threonine Kinases, Transcription Factors, Adaptor Proteins, Signal Transducing, Intracellular Signaling Peptides and Proteins. Die Arbeit nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Terry Fox Research Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Disruption of the Hippo pathway leads to activation of the YAP/TAZ transcriptional program which promotes tumor initiation, progression and metastasis in diverse cancers. Aggressive triple-negative breast cancers (TNBC) lack an effective therapy; thus, inactivating YAP and TAZ has emerged as an attractive approach and a new treatment modality. Thus, we performed two complementary high-throughput RNAi-based kinome screens to uncover cancer-associated activators of YAP/TAZ in two TNBC cell lines, MDA-MB231 and MDA-MB468. Integrated analysis that combined a YAP/TAZ localization screen with a TEAD-luciferase reporter screen, identified novel regulators including BRSK1, STK32C and STK40. The AMPK family members NUAKs, MARKs and SIKs are known to inhibit the Hippo kinase cassette; here, we uncover BRSK1, another AMPK family member as a regulator of YAP/TAZ. We also reveal that two poorly studied kinases, STK32C, a member of the AGC family, and STK40, a pseudokinase, can also inhibit the activity of YAP/TAZ. Thus, our studies expand the repertoire of known AMPK family members and reveal two new kinases that modulate the Hippo pathway and may play a role in YAP/TAZ driven breast cancers. Further analysis of other screen hits may similarly uncover new regulators that could be targeted for therapeutic interventions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Protein Serine-Threonine KinasesTranscription FactorsAdaptor Proteins, Signal TransducingIntracellular Signaling Peptides and ProteinsTriple Negative Breast NeoplasmsHumansCell Line, TumorYAP-Signaling ProteinsHigh-Throughput Screening AssaysRNA InterferenceFemaleSignal TransductionGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

AMPK family membersBRSK1Hippo pathwayRNAi screeningSTK32CSTK40YAP/TAZtriple-negative breast cancer

Substanzen

Protein Serine-Threonine KinasesTranscription FactorsAdaptor Proteins, Signal TransducingYAP-Signaling ProteinsIntracellular Signaling Peptides and ProteinsYAP1 protein, human

Autor:innen und Institutionen

  • Department of Biochemistry, Donnelly Centre, University of Toronto, Toronto, ON M5S 3E1, Canada.

ORCID-Profile: Liliana Attisano

Förderung

  • Terry Fox Research Institute

Zitieren

APA

Gill, M. K., Song, S., Christova, T., & Attisano, L. (2025). Integrative High-Throughput RNAi Screening Identifies BRSK1, STK32C and STK40 as Novel Activators of YAP/TAZ. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26167810

Vancouver

Gill MK, Song S, Christova T, Attisano L. Integrative High-Throughput RNAi Screening Identifies BRSK1, STK32C and STK40 as Novel Activators of YAP/TAZ. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26167810

BibTeX
@article{Gill2025,
  author = {Gill, Mandeep K and Song, Siyuan and Christova, Tania and Attisano, Liliana},
  title = {Integrative High-Throughput RNAi Screening Identifies BRSK1, STK32C and STK40 as Novel Activators of YAP/TAZ},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26167810}
}
Kostenlos starten →